Jianmin Xu

Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With <i>KRAS</i> Wild-Type Unresectable Colorectal Liver-Limited Metastases

Lechi Ye, Tianshu Liu, Li Ren et al. · Journal of Clinical Oncology · 2013 · 390 citations · Full text

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7

Wentao Tang, Meiling Ji, Guodong He et al. · OncoTargets and Therapy · 2017 · 178 citations · Full text

Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer

Qingyang Feng, Wenju Chang, Yihao Mao et al. · Clinical Cancer Research · 2019 · 155 citations · Full text

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer

Yihao Mao, Qingyang Feng, Peng Zheng et al. · Cancer Management and Research · 2018 · 144 citations · Full text

Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression

Qixia Xu, Qilai Long, Dexiang Zhu et al. · Aging Cell · 2019 · 133 citations · Full text